Ritalinic acid
Major metabolite of the psychostimulant drug methylphenidate
From Wikipedia, the free encyclopedia
Ritalinic acid is a substituted phenethylamine and an inactive major metabolite of the psychostimulant drugs methylphenidate, dexmethylphenidate and ethylphenidate.[1][2] When administered orally, methylphenidate is extensively metabolized in the liver by hydrolysis of the ester group yielding ritalinic acid.[1] The hydrolysis was found to be catalyzed by carboxylesterase 1 (CES1).[3]
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.039.094 |
| Chemical and physical data | |
| Formula | C13H17NO2 |
| Molar mass | 219.284 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Etymologically, ritalinic acid shares its roots with Ritalin, a common brand name for methylphenidate.
Uses
Ritalinic acid is used as an intermediate in the synthesis of methylphenidate and its analogues, such as ethylphenidate and isopropylphenidate.